泽璟制药-U股价报112.60元科创板百元股医药板块占8席

金融界07-09

截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2550578616?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-09 03:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550578616","market":"hk","top_or_hot":-1,"title":"泽璟制药-U股价报112.60元 科创板百元股医药板块占8席","media":"金融界","content":"<div>\n<p>截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/07/09034551571633.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泽璟制药-U股价报112.60元 科创板百元股医药板块占8席</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泽璟制药-U股价报112.60元 科创板百元股医药板块占8席\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-09 03:45 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/07/09034551571633.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/07/09034551571633.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/07/09034551571633.shtml","article_id":"2550578616","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550578616","pubTimestamp":1752003941,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动模式。数据显示，科创板市场目前共有39只百元股，其中医药生物行业占据8席。在当日交易中，泽璟制药-U主力资金净流出5647.52万元。风险提示：股市有风险，投资需谨慎。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","159982":"中证500","688266":"泽璟制药","BK0239":"医药制造","09939":"开拓药业-B","BK1574":"生物医药B类股","BK1161":"生物科技","BK1515":"抗疫概念"},"translate_title":"The stock price of Zejing Pharmaceutical-U was reported at 112.60 yuan, and the pharmaceutical sector accounted for 8 seats in the 100-yuan stock on the Science and Technology Innovation Board","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"159982":1,"688266":1,"09939":1},"content_text":"截至2025年7月8日15时，泽璟制药-U股价报112.60元，较前一交易日下跌2.60元。当日开盘价为114.58元，最高触及117.98元，最低下探至112.20元，成交量为34955手，成交金额达3.99亿元。泽璟制药-U属于科创板医药生物板块企业，专注于肿瘤、出血及血液疾病、免疫炎症性疾病等领域的创新药物研发。公司采用精准小分子药物研发及产业化平台和复杂重组蛋白新药研发及产业化平台双轮驱动模式。数据显示，科创板市场目前共有39只百元股，其中医药生物行业占据8席。在当日交易中，泽璟制药-U主力资金净流出5647.52万元。风险提示：股市有风险，投资需谨慎。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2550578616","isCrawlerRequest":true}

泽璟制药-U股价报112.60元 科创板百元股医药板块占8席

精彩评论

泽璟制药-U股价报112.60元科创板百元股医药板块占8席